These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8777981)

  • 1. Nongranulomatous interstitial lung disease in Crohn's disease.
    Hotermans G; Benard A; Guenanen H; Demarcq-Delerue G; Malart T; Wallaert B
    Eur Respir J; 1996 Feb; 9(2):380-2. PubMed ID: 8777981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mesalazine-related interstitial lung disease: an under-diagnosed effect?].
    Auffret M; Béné J; Lambert M; Gautier S
    Therapie; 2014; 69(6):531-2. PubMed ID: 25320942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
    Uittenbogaart SB; Klemt-Kropp M
    Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn's disease.
    Faller M; Gasser B; Massard G; Pauli G; Quoix E
    Respiration; 2000; 67(4):459-63. PubMed ID: 10940806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's disease-associated interstitial lung disease mimicking sarcoidosis: a case report and review of the literature.
    Thao C; Lagstein A; Allen T; Dincer HE; Kim HJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):288-291. PubMed ID: 27758996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease.
    Hämling J; Raedler A; Helmchen U; Schreiber S
    Digestion; 1997; 58(3):304-7. PubMed ID: 9243128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mesalazine-induced eosinophilic pneumonia in a patient with Crohn's disease].
    Park JE; Hwangbo Y; Chang R; Chang YW; Jang JY; Kim BH; Dong SH; Kim HJ
    Korean J Gastroenterol; 2009 Feb; 53(2):116-20. PubMed ID: 19237838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?
    Sahmoud T; Mary JY; Sahmoud T
    Gut; 1997 Feb; 40(2):284-5. PubMed ID: 9071946
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pneumonitis caused by mesalazine].
    Pascual Lledó F; Calvo Bonachera J; Carrasco Miras F; Sánchez-Martínez H
    Arch Bronconeumol; 1997 Jun; 33(6):309-11. PubMed ID: 9289328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninfectious interstitial lung disease during infliximab therapy: case report and literature review.
    Caccaro R; Savarino E; D'Incà R; Sturniolo GC
    World J Gastroenterol; 2013 Aug; 19(32):5377-80. PubMed ID: 23983443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary complications in patients with inflammatory bowel disease.
    Kuzela L; Vavrecka A; Prikazska M; Drugda B; Hronec J; Senkova A; Drugdova M; Oltman M; Novotna T; Brezina M; Kratky A; Kristufek P
    Hepatogastroenterology; 1999; 46(27):1714-9. PubMed ID: 10430329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis.
    de Souza RB; Borges CT; Capelozzi VL; Parra ER; Jatene FB; Kavakama J; Kairalla RA; Bonfá E
    Respiration; 2009; 77(4):389-97. PubMed ID: 18799868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease].
    García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J
    Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
    Modigliani R; Colombel JF; Dupas JL; Dapoigny M; Costil V; Veyrac M; Duclos B; Soulé JC; Gendre JP; Galmiche JP; Danne O; Cadiot G; Lamouliatte H; Belaïche J; Mary JY
    Gastroenterology; 1996 Mar; 110(3):688-93. PubMed ID: 8608877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
    Netzer P
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of juvenile ankylosing spondylitis and Crohn's disease.
    Unsal E; Eroğlu Y; Büyükgebiz B; Küpelioğlu A; Cevik NT
    Turk J Pediatr; 1997; 39(2):277-80. PubMed ID: 9223928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesalazine-induced lung fibrosis.
    Alskaf E; Aljoudeh A; Edenborough F
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23576654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholestasis associated with mesalazine therapy in a patient with Crohn's disease.
    Stoschus B; Meybehm M; Spengler U; Scheurlen C; Sauerbruch T
    J Hepatol; 1997 Feb; 26(2):425-8. PubMed ID: 9059966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's disease and acute leukocytoclastic vasculitis of skin.
    Zlatanic J; Fleisher M; Sasson M; Kim P; Korelitz BI
    Am J Gastroenterol; 1996 Nov; 91(11):2410-3. PubMed ID: 8931427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of subacute idiopathic interstitial pneumonia resistant to steroids, successfully treated with cyclophosphamide].
    Ozawa Y; Ida M; Suda T; Katou M; Enomoto N; Fujii M; Nogimura H; Chida K; Nakamura H
    Nihon Kokyuki Gakkai Zasshi; 2004 Nov; 42(11):945-50. PubMed ID: 15651274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.